4 reports of this reaction
2.0% of all COCOA BUTTER, PHENYLEPHRINE HCL reports
#4 most reported adverse reaction
CONSTIPATION is the #4 most commonly reported adverse reaction for COCOA BUTTER, PHENYLEPHRINE HCL, manufactured by Amerisourcebergen Drug Corporation. There are 4 FDA adverse event reports linking COCOA BUTTER, PHENYLEPHRINE HCL to CONSTIPATION. This represents approximately 2.0% of all 199 adverse event reports for this drug.
Patients taking COCOA BUTTER, PHENYLEPHRINE HCL who experience constipation should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CONSTIPATION is a less commonly reported adverse event for COCOA BUTTER, PHENYLEPHRINE HCL, but still significant enough to appear in the safety profile.
In addition to constipation, the following adverse reactions have been reported for COCOA BUTTER, PHENYLEPHRINE HCL:
The following drugs have also been linked to constipation in FDA adverse event reports:
CONSTIPATION has been reported as an adverse event in 4 FDA reports for COCOA BUTTER, PHENYLEPHRINE HCL. This does not prove causation, but indicates an association observed in post-market surveillance data.
CONSTIPATION accounts for approximately 2.0% of all adverse event reports for COCOA BUTTER, PHENYLEPHRINE HCL, making it a notable side effect.
If you experience constipation while taking COCOA BUTTER, PHENYLEPHRINE HCL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.